Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2008-01-31
2012-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Error-enhanced Learning & Recovery in 2 & 3 Dimensions
NCT05180786
Error Augmentation Training Post Stroke
NCT03578250
Deficit Fields for Stroke Recovery
NCT02570256
In Home VR Therapy
NCT03062345
Feasibility and Effectiveness of Goal Driven Extended Reality for Lower Limb Rehabilitation
NCT07043101
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Error Augmentation-Control
Error Augmentation
error augmentation for arm motor recovery in individuals with stroke
Control-Error Augmentation
Error Augmentation
error augmentation for arm motor recovery in individuals with stroke
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Error Augmentation
error augmentation for arm motor recovery in individuals with stroke
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* survived a single cortical stroke at least 6 months previously involving ischemia or hemorrhage of the middle cerebral artery (MCA),
* demonstrated the presence of some active shoulder and elbow movement (characterized by Fugl-Meyer Assessment Upper Extremity scores ranging from 15-50 for ARM 1; 25-50 for ARM 2).
Exclusion Criteria
* bilateral paresis
* severe spasticity or contracture (Modified Ashworth ≥3
* severe concurrent medical problems
* severe sensory deficits
* cerebellar strokes resulting in severe ataxia
* significant shoulder pain
* focal tone management with Botulinim Toxin (Botox®) injection to the hemiparetic upper extremity (UE) within the previous four months,
* aphasia that would influence the ability to perform the experiment
* cognitive impairment (Mini Mental State Examination \< 23/30)
* affective dysfunction that would influence the ability to perform the experiment
* depth perception impairment (\< 3 on Stereo Circle Test)
* visual field cut or hemispatial neglect that would influence the ability to participate in the activity
* inability to provide informed consent
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
U.S. Department of Education
FED
Shirley Ryan AbilityLab
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
James Patton
Co-Director, Robotics Laboratory, Sensory Motor Performance Program, Rehabilitation Institute of Chicago
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
James Patton, PhD
Role: PRINCIPAL_INVESTIGATOR
Shirley Ryan AbilityLab
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rehabilitation Institute of Chicago
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STU00002311
Identifier Type: OTHER
Identifier Source: secondary_id
H133E0700 13
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.